Research and development

Main objetives

Production and commercialization of products and diagnostics tests using recombinant DNA technology (proteins / monoclonal antibodies) according to international and local regulations (INAME/FDA/EMEA).

Agreements with biotechnology industry leadership companies in order to achieve the national and international market with own and/or licensed products.   

Identification of leading products, and development of projects considering the advances of pioneers countries in the discovery of new biopharmaceutical niches, to generate products that will fit the market needs.

Perspectives

Construction of an own GMP facility

Development and production of 2nd and 3rd generation biopharmaceutical products: humanized monoclonal antibodies, glycopeglation, protein reengineering in a GMP facility.